Foscavir and Hyperlipidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlipidaemia is reported as a side effect among people who take Foscavir (foscarnet sodium), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Prednisolone, and have Hiv infection.

The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Foscavir. It is created by eHealthMe based on reports of 1,631 people who have side effects when taking Foscavir from the FDA, and is updated regularly.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,423 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

1,631 people reported to have side effects when taking Foscavir.
Among them, 32 people (1.96%) have Hyperlipidaemia.

Among these 32 people:

How long have people been on Foscavir when they have Hyperlipidaemia? *

What is the gender of people who have Hyperlipidaemia when taking Foscavir? *

female: 46.88 %
male: 53.12 %

What is the age of people who have Hyperlipidaemia when taking Foscavir? *

What are other drugs people take besides Foscavir? *

What are other side effects people have besides Hyperlipidaemia? *

Nausea (feeling of having an urge to vomit): 21 people, 65.62%
Blood Alkaline Phosphatase Increased: 16 people, 50.00%
Gamma-Glutamyltransferase Increased: 13 people, 40.62%
Mycobacterium Avium Complex Infection: 13 people, 40.62%
Renal Impairment (severely reduced kidney function): 13 people, 40.62%
Nausea And Vomiting: 12 people, 37.50%
Dizziness: 12 people, 37.50%
Electrolyte Imbalance: 11 people, 34.38%
Calculus Urinary (stone in urinary system): 11 people, 34.38%
Diarrhea: 11 people, 34.38%

What are the existing conditions these people have? *

Hiv Infection: 20 people, 62.50%
Mycobacterium Avium Complex Infection: 18 people, 56.25%
Cytomegalovirus Infection: 15 people, 46.88%
Osteoporosis (bones weak and more likely to break): 11 people, 34.38%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 9 people, 28.12%
Headache (pain in head): 9 people, 28.12%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 9 people, 28.12%
Dizziness: 9 people, 28.12%
Hypotension (abnormally low blood pressure): 9 people, 28.12%
Insomnia (sleeplessness): 9 people, 28.12%

* Approximation only. Some reports may have incomplete information.

Do you take Foscavir and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Foscavir:

Foscavir (1,631 reports)

Hyperlipidaemia treatments and more:

Hyperlipidaemia (86,394 reports)

Browse all side effects of Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,423 drugs)

Browse all the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on foscarnet sodium (the active ingredients of Foscavir) and Foscavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.